Emerson: Predictive intelligence to reduce operating costs at biopharmaceutical plant
Predictive intelligence software, which anticipates what needs to be done to maintain optimal operations, will be used in a new $350 million Lonza biopharmaceutical plant in Singapore, with help from Emerson Process Management.
-- Manufacturing Business Technology, 5/28/2009 9:47:45 AM
Predictive intelligence software, which anticipates what needs to be done to maintain optimal operations, will be used in a new $350 million Lonza biopharmaceutical plant in Singapore, with help from Emerson Process Management.
Predictive intelligence technology, software that anticipates what needs to be done to maintain optimal operations, will be used in a new Lonza biopharmaceutical plant in Singapore. Switzerland-based Lonza Group Ltd. Selected Emerson Process Management to provide engineering and design services and digital automation architecture and control technologies.
Competitive pressures drive life sciences companies toward digital automation with predictive intelligence to reduce overall costs, improve reliability, ensure product quality, meet regulatory requirements, and optimize operations, says Emerson of its increasing number of life sciences customers.
Best practices reduce costs in second Lonza plant
Having installed the automation architecture in Lonza's first biopharmaceutical plant in Singapore, Emerson PlantWeb technologies were chosen for the new plant, expected to be completed in 2010 at a cost of $350 million. By following the original project models, employing best practices, and applying the experience gained during design and construction of the original facility, Emerson is expected to reduce Lonza's overall costs for the new plant.
Lonza uses Emerson products and services, including: PlantWeb digital automation architecture; DeltaV digital automation system; and intelligent digital devices, including Fisher and Baumann control valves with Fieldvue digital valve controllers, Rosemount flowmeters and analyzers, Micro Motion Coriolis flowmeters, and Fisher pressure regulators.
Faster startups, greater reliability cited
Managing and controlling the highly complex processes involved in the biopharmaceutical industry is among Emerson strengths, says Steve Sonnenberg, president, Emerson Process Management. Global resources of Emerson help meet customers' objectives for safe, reliable, and on-time start-up of new manufacturing facilities, he says.
In the Asia-Pacific region, Emerson also has been awarded automation contracts by Shanghai CP Guojian Pharmaceutical Co. Ltd. in China; Reliance Life Sciences, DSM Anti-Infectives India Ltd., and Biocon in India; and the prior Lonza facility in Singapore.
For other recent Emerson news from MBT, see:
- Cyber security: Safety instrumented systems, 5 incidents
- Big buzz: Not all wireless was created equal
- Smart operations management: Emerson touts new software as MES replacement
- Edited by Mark T. Hoske, electronic products editor, MBT, www.mbtmag.com
